全文获取类型
收费全文 | 45283篇 |
免费 | 4096篇 |
国内免费 | 64篇 |
专业分类
耳鼻咽喉 | 509篇 |
儿科学 | 1264篇 |
妇产科学 | 1168篇 |
基础医学 | 6204篇 |
口腔科学 | 997篇 |
临床医学 | 5041篇 |
内科学 | 9139篇 |
皮肤病学 | 513篇 |
神经病学 | 3784篇 |
特种医学 | 1459篇 |
外国民族医学 | 9篇 |
外科学 | 5856篇 |
综合类 | 868篇 |
一般理论 | 40篇 |
预防医学 | 5251篇 |
眼科学 | 1041篇 |
药学 | 3297篇 |
中国医学 | 49篇 |
肿瘤学 | 2954篇 |
出版年
2021年 | 664篇 |
2020年 | 407篇 |
2019年 | 670篇 |
2018年 | 799篇 |
2017年 | 650篇 |
2016年 | 631篇 |
2015年 | 722篇 |
2014年 | 1083篇 |
2013年 | 1644篇 |
2012年 | 2417篇 |
2011年 | 2527篇 |
2010年 | 1347篇 |
2009年 | 1253篇 |
2008年 | 2244篇 |
2007年 | 2420篇 |
2006年 | 2367篇 |
2005年 | 2262篇 |
2004年 | 2131篇 |
2003年 | 1987篇 |
2002年 | 1988篇 |
2001年 | 1217篇 |
2000年 | 1247篇 |
1999年 | 1080篇 |
1998年 | 487篇 |
1997年 | 441篇 |
1996年 | 431篇 |
1995年 | 368篇 |
1994年 | 363篇 |
1993年 | 342篇 |
1992年 | 948篇 |
1991年 | 931篇 |
1990年 | 847篇 |
1989年 | 791篇 |
1988年 | 691篇 |
1987年 | 711篇 |
1986年 | 709篇 |
1985年 | 695篇 |
1984年 | 568篇 |
1983年 | 450篇 |
1982年 | 349篇 |
1981年 | 301篇 |
1980年 | 269篇 |
1979年 | 534篇 |
1978年 | 331篇 |
1977年 | 265篇 |
1976年 | 287篇 |
1975年 | 320篇 |
1974年 | 354篇 |
1973年 | 293篇 |
1972年 | 276篇 |
排序方式: 共有10000条查询结果,搜索用时 171 毫秒
981.
982.
Zimring JC Hair GA Chadwick TE Deshpande SS Anderson KM Hillyer CD Roback JD 《Blood》2005,106(3):1105-1112
Transfusion of red blood cells (RBCs) into patients with anti-donor RBC antibodies (crossmatch-incompatible transfusion) can result in lethal antibody-mediated hemolysis. Less well appreciated is the ability of anti-RBC antibodies to specifically remove their target antigen from donor RBCs without compromising cell survival or adversely affecting the transfusion recipient. In an effort to elucidate the mechanistic details of this process, we describe the first animal model of nonhemolytic antibody-induced RBC antigen loss. RBCs from transgenic mHEL mice express surface hen egg lysozyme (HEL) as a transmembrane protein. Transfusion of mHEL RBCs into mice immunized with HEL results in selective loss of HEL antigen from donor RBCs without affecting other blood group antigens or reducing the circulatory life span of the transfused RBCs. While this process does not require the presence of a spleen, it requires both anti-RBC immunoglobulin G (IgG) antibodies and the FcgammaIII receptor. These studies provide mechanistic insight into the phenomenon of antigen loss during incompatible transfusion in humans. 相似文献
983.
Use of angiotensin-converting enzyme inhibitor therapy and dose-related outcomes in older adults with new heart failure in the community 下载免费PDF全文
Rochon PA Sykora K Bronskill SE Mamdani M Anderson GM Gurwitz JH Gill S Tu JV Laupacis A 《Journal of general internal medicine》2004,19(6):676-683
OBJECTIVE: To evaluate the dose-related benefit of angiotensin-converting enzyme (ACE) inhibitor therapy among older adults with heart failure and to evaluate whether low-dose ACE inhibitor therapy is better than none. DESIGN: Observational cohort study. SETTING: Community-dwelling older adults in Ontario, Canada. PATIENTS/PARTICIPANTS: We identified 16539 adults 66 years or older who survived 45 days following their first heart failure hospitalization discharge. MEASUREMENT AND MAIN RESULTS: Multivariate techniques including propensity scores were used to study the association between the dose of ACE inhibitor therapy dispensed and 3 outcomes: survival, survival or heart failure rehospitalization, and survival or all-cause hospitalization at 1 year of follow-up. Logistic regression models explored the association between initial dose dispensed and subsequent dose reduction or drug cessation. Overall, 10793 (65.3%) of patients were dispensed ACE inhibitor therapy, with more than a third (3935; 36.5%) initiated on low-dose therapy. Relative to dispensing of low-dose ACE inhibitor therapy, nonuse was associated with increased mortality (hazard ratio [HR], 1.12; 95% confidence interval [CI], 1.02 to 1.22). Dispensing medium-dose therapy provided a benefit similar to low-dose (HR, 0.94; CI, 0.86 to 1.03) and dispensing of high-dose therapy was associated with improved survival benefit (HR, 0.76; CI, 0.68 to 0.85). Relative to dispensing of low-dose ACE inhibitor therapy, dispensing high-dose conferred a benefit (HR, 0.87; CI, 0.80 to 0.95) on the composite outcome of 1-year mortality or heart failure hospitalization and the composite outcome of 1-year mortality or all-cause hospitalization (HR, 0.87; CI, 0.81 to 0.93). Relative to those dispensed low-dose ACE inhibitor therapy, those initially dispensed high-dose therapy were twice as likely to have their subsequent dose reduced or the therapy discontinued (odds ratio, 2.36; CI, 2.07 to 2.69). CONCLUSION: Our findings suggest that when possible, older adults should be titrated to the higher doses of ACE inhibitor therapy evaluated in clinical trials. If older adults cannot tolerate higher doses, then low-dose ACE inhibitor therapy is superior to none. High-dose ACE inhibitor therapy is not as well tolerated as lower doses. 相似文献
984.
985.
Sixty-six hearts were examined in which a single arterial trunk, leaving the base of the heart through a single semilunar valve, supplied the aorta, pulmonary artery and coronary arteries. Careful attention was paid to the infundibular morphologic features in these hearts, and these were compared with findings in 24 hearts with single aortic trunk, pulmonary atresia and ventricular septal defect. It was concluded that the two anomalies represented morphologically discrete conditions. This was particularly true with regard to the disposition of the infundibular septum, the ventriculo-infundibular fold and the relation of the coronary arteries to the semilunar sinuses. Although it is theoretically possible for a heart with true persistent truncus arteriosus to have absence of the pulmonary trunk and right and left pulmonary arteries, it is argued that such hearts (“truncus type IV”) are best classified as pulmonary atresia with ventricular septal defect. It is also argued that hearts with a common arterial trunk supplied through discrete ventricular outflow tracts and two semilunar valves are best considered examples of aorticopulmonary window. It is suggested that persistent truncus arteriosus is best defined as that condition in which a single arterial trunk leaves the heart through a single semilunar valve and supplies the aorta, one or both pulmonary arteries and the coronary arteries. 相似文献
986.
Global profiling of Shewanella oneidensis MR-1: expression of hypothetical genes and improved functional annotations 总被引:1,自引:0,他引:1 下载免费PDF全文
Kolker E Picone AF Galperin MY Romine MF Higdon R Makarova KS Kolker N Anderson GA Qiu X Auberry KJ Babnigg G Beliaev AS Edlefsen P Elias DA Gorby YA Holzman T Klappenbach JA Konstantinidis KT Land ML Lipton MS McCue LA Monroe M Pasa-Tolic L Pinchuk G Purvine S Serres MH Tsapin S Zakrajsek BA Zhu W Zhou J Larimer FW Lawrence CE Riley M Collart FR Yates JR Smith RD Giometti CS Nealson KH Fredrickson JK Tiedje JM 《Proceedings of the National Academy of Sciences of the United States of America》2005,102(6):2099-2104
987.
988.
989.